Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
10.40
+0.39 (3.90%)
Nov 6, 2026, 4:00 PM EST - Market closed

Vicore Pharma Holding AB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
291345179158141110
Market Cap Growth
12.13%92.70%13.69%12.08%27.22%-52.33%
Enterprise Value
21325414510312461

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
759.39833.4418.13---
PB Ratio
4.012.901.763.485.072.61
P/TBV Ratio
4.012.901.763.506.633.16

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
555.64614.4614.65---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----00.00
Net Debt / Equity Ratio
-1.06-1.06-1.02-1.06-0.90-0.97
Net Debt / EBITDA Ratio
-2.586.151.520.921.28
Net Debt / FCF Ratio
1.573.117.011.930.871.40
Asset Turnover
0.010.000.13---
Quick Ratio
8.529.9917.9011.865.695.67
Current Ratio
8.8810.2818.2012.105.815.75
Return on Equity (ROE)
-68.83%-42.92%-21.28%-83.53%-85.79%-80.37%
Return on Assets (ROA)
-41.10%-23.53%-14.05%-47.99%-45.54%-42.76%
Return on Capital Employed (ROCE)
-76.20%-41.30%-16.80%-70.20%-98.60%-76.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-18.58%-15.01%-8.51%-19.63%-19.69%-29.68%
FCF Yield
-17.02%-11.81%-8.32%-15.75%-20.47%-26.55%
Buyback Yield / Dilution
-19.76%-75.30%-41.72%-33.71%-3.64%-28.44%